Glen Weiss to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Glen Weiss has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.497
-
Mckane A, Sima C, Ramanathan RK, Jameson G, Mast C, White E, Fleck S, Downhour M, Von Hoff DD, Weiss GJ. Determinants of patient screen failures in Phase 1 clinical trials. Invest New Drugs. 2013 Jun; 31(3):774-9.
Score: 0.396
-
Caldwell S, Sima C, Jameson G, Fleck S, Weiss GJ. Factors influencing time to determination of the recommended phase 2 dose in phase 1 clinical trials. Am J Clin Oncol. 2013 Apr; 36(2):146-50.
Score: 0.102